BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 18996106)

  • 1. A case of hook effect in the serum free light chain assay using the Olympus AU400e.
    McCudden CR; Voorhees PM; Hammett-Stabler CA
    Clin Biochem; 2009 Jan; 42(1-2):121-4. PubMed ID: 18996106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of monoclonal protein in 72 cases of multiple myeloma].
    Yang JJ; Zhang GS; Chen XR
    Hunan Yi Ke Da Xue Xue Bao; 2001 Apr; 26(2):152-4. PubMed ID: 12536652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the efficiency of free light chain assay in monitoring patients with multiple myeloma before and after autologous stem cell transplantation along with serum protein electrophoresis and serum protein immunofixation.
    Dogaru M; Lazăr V; Coriu D
    Roum Arch Microbiol Immunol; 2011; 70(1):15-22. PubMed ID: 21717807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma.
    Kang SY; Suh JT; Lee HJ; Yoon HJ; Lee WI
    Ann Hematol; 2005 Sep; 84(9):588-93. PubMed ID: 15883850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma.
    Kyrtsonis MC; Vassilakopoulos TP; Kafasi N; Sachanas S; Tzenou T; Papadogiannis A; Galanis Z; Kalpadakis C; Dimou M; Kyriakou E; Angelopoulou MK; Dimopoulou MN; Siakantaris MP; Dimitriadou EM; Kokoris SI; Panayiotidis P; Pangalis GA
    Br J Haematol; 2007 May; 137(3):240-3. PubMed ID: 17408464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hook effect with lambda free light chain in serum free light chain assay.
    Levinson SS
    Clin Chim Acta; 2010 Nov; 411(21-22):1834-6. PubMed ID: 20667445
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation of the clinical relevance of serum measurements of free-light chains in patients with multiple myeloma].
    Shimizu K; Itoh J; Sugiura I; Tsushita K; Kosugi H; Nagura E
    Rinsho Ketsueki; 2006 Apr; 47(4):303-9. PubMed ID: 16715965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Assessment of serum free light chain of patients with multiple myeloma and clinical significance thereof].
    Sui WW; Yao HJ; Wang YF; Wang L; Zhang K; Xu Y; Qiu LG
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3158-60. PubMed ID: 18269880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection of serum free light chain and its clinical significance in nonsecretory multiple myeloma].
    Chen HF; Hou J; Yuan ZG; Wang DX; Fu WJ; Chen YB
    Zhonghua Xue Ye Xue Za Zhi; 2008 Feb; 29(2):113-6. PubMed ID: 18681313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can serum free light chains replace urine electrophoresis in the detection of monoclonal gammopathies?
    Beetham R; Wassell J; Wallage MJ; Whiteway AJ; James JA
    Ann Clin Biochem; 2007 Nov; 44(Pt 6):516-22. PubMed ID: 17961305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evolving use of serum free light chain assays in haematology.
    Pratt G
    Br J Haematol; 2008 May; 141(4):413-22. PubMed ID: 18318757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum free light chain analysis may miss monoclonal light chains that urine immunofixation electrophoreses would detect.
    Shaheen SP; Levinson SS
    Clin Chim Acta; 2009 Aug; 406(1-2):162-6. PubMed ID: 19410572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure.
    Hutchison CA; Plant T; Drayson M; Cockwell P; Kountouri M; Basnayake K; Harding S; Bradwell AR; Mead G
    BMC Nephrol; 2008 Sep; 9():11. PubMed ID: 18808676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analytical performance of serum free light-chain assay during monitoring of patients with monoclonal light-chain diseases.
    Tate JR; Mollee P; Dimeski G; Carter AC; Gill D
    Clin Chim Acta; 2007 Feb; 376(1-2):30-6. PubMed ID: 16945362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum free light chain analysis in B-cell dyscrasias.
    Ramasamy I
    Ann Clin Lab Sci; 2007; 37(3):291-4. PubMed ID: 17709698
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum free light chains for monitoring multiple myeloma.
    Mead GP; Carr-Smith HD; Drayson MT; Morgan GJ; Child JA; Bradwell AR
    Br J Haematol; 2004 Aug; 126(3):348-54. PubMed ID: 15257706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of monoclonal free light chains in the serum predicts risk of progression in monoclonal gammopathy of undetermined significance.
    Rajkumar SV; Kyle RA; Therneau TM; Clark RJ; Bradwell AR; Melton LJ; Larson DR; Plevak MF; Katzmann JA
    Br J Haematol; 2004 Nov; 127(3):308-10. PubMed ID: 15491291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. POEMS Syndrome with IgG-λ/IgA-κ Biclonal Gammopathy and Abnormal Serum Free Light Chain Ratio: a Case Report.
    Ham JY; Suh JS; Lee WK; Song KE
    Ann Clin Lab Sci; 2015; 45(6):702-6. PubMed ID: 26663802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Kidney failure in a patient with chronic B-lymphocytic leukaemia (B-CLL) with underlying cast nephropathy. The value of free immunoglobulin light chain identification for early diagnosis of this complication].
    Adam Z; Stepánková S; Sirotková A; Cermáková Z; Pour L; Krejcí M; Zahradová L; Korístek Z; Lenz J; Hájek R; Vorlícek J; Mayer J
    Vnitr Lek; 2011 Feb; 57(2):214-21. PubMed ID: 21416862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum free light chain (FLC) measurement can aid capillary zone electrophoresis in detecting subtle FLC-producing M proteins.
    Bakshi NA; Gulbranson R; Garstka D; Bradwell AR; Keren DF
    Am J Clin Pathol; 2005 Aug; 124(2):214-8. PubMed ID: 16040291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.